2019
DOI: 10.1016/j.cej.2018.10.202
|View full text |Cite
|
Sign up to set email alerts
|

Efficient removal of the pharmaceutical pollutants included in the EU Watch List (Decision 2015/495) by modified magnetite/H2O2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 52 publications
1
8
0
Order By: Relevance
“…% H 2 in N 2 ) for 3 h at 400 ºC. A detailed characterization of the catalyst, including XRD, textural properties, and magnetic measurements, can be found elsewhere (Álvarez-Torrellas et al, 2018;Serrano et al, 2018). Summarizing, the iron content was 73% wt., the specific surface area 7 m 2 g -1 and the particles showed a mean size of 0.2 m.…”
Section: Magnetite Modification and Characterizationmentioning
confidence: 99%
“…% H 2 in N 2 ) for 3 h at 400 ºC. A detailed characterization of the catalyst, including XRD, textural properties, and magnetic measurements, can be found elsewhere (Álvarez-Torrellas et al, 2018;Serrano et al, 2018). Summarizing, the iron content was 73% wt., the specific surface area 7 m 2 g -1 and the particles showed a mean size of 0.2 m.…”
Section: Magnetite Modification and Characterizationmentioning
confidence: 99%
“…The powdered Fe3O4 catalyst was fully characterized in previous work [21]. Briefly, the iron content was close to the theoretical one for pure magnetite (73 wt.%).…”
Section: Catalyst Characterizationmentioning
confidence: 53%
“…To develop low‐cost catalyst, Serrano, Munoz, Pedro, and Casas (2019) studied the effect of catalytic system based on modified natural magnetite (Fe 3 O 4 ‐R400) and H 2 O 2 on the removal of all the pharmaceuticals in the EU Watch List (estrone, 17‐beta‐estradiol, 17‐alpha‐ethinylestradiol, azithromycin, clarithromycin, erythromycin, and diclofenac). The experimental parameters were set as follows: treatment temperature 17–50°C, initial pharmaceutical concentration 1,000 μg/L, and initial pH value of system 5.…”
Section: Catalysis (Photolysis/photocatalysis Fenton Processes)mentioning
confidence: 99%